AzTrials
AzTrials

DementiaAATPDNCT03946696

Animal-Assisted Therapy for People With Dementia

An observational study of Dementia, run by University of Aberdeen at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study is a qualitative anthropological research that explores the effects of Animal-Assisted Therapy (AAT) for people with moderate and severe dementia living in a care facility. Read more about this study

Who is it for?
Ages 55 to 100 years
Conditions the study is for
Dementia
What is being tested?
Interactions with therapy-animals
How many people
20 participants
Where
1 siteUnited Kingdom
Study dates
15 Jan 2022to 31 Dec 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 55 to 100 years
  • All sexes
  • Adult, Older adult

Study population: People with moderate and severe dementia living in a care home; who are visited by therapy-animal teams.

Who may be able to join

  • People diagnosed with moderate and severe dementia living in a nursing home, age range 55-100.
  • The above-mentioned participants who receive therapy-animal services.

Who cannot join

  • People with other medical conditions who receive visits from therapy-animals and who do not reside in a care home.
  • People with dementia who do not reside in a care home.
  • People with dementia younger than 55 years old who live in their own home.

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • University of Aberdeen

    Aberdeen, Aberdeenshire, AB25 2ZB

Other trials in United Kingdom

About this study

Official title: Bonding at the Very End Emerging Personhood During End-of-life and Palliative Care Through Animal-Assisted Therapy (AAT)

This study is a qualitative anthropological research that explores the effects of Animal-Assisted Therapy (AAT) for people with moderate and severe dementia living in a care facility. In particular, the study explores the effects that AAT can have on people with moderate and later stages of dementia, living in a care facility, on: Behavioural and Psychological Symptoms of Dementia (BPSD); mood (depression); quality of life; activity (physical). The AAT effects on people with moderate and later stages of dementia will be compared with effects that other activities provided in the care facility where participants live, may have on the same participants.

This study does not test hypotheses.

Read the detailed description

This study is a qualitative anthropological research that explores the effects of Animal-Assisted Therapy (AAT) for people with moderate and severe dementia living in a care facility. In particular, the study explores the effects that AAT can have on people with moderate and later stages of dementia, living in a care facility, on: Behavioural and Psychological Symptoms of Dementia (BPSD); mood (depression); quality of life; activity (physical). The AAT effects on people with moderate and later stages of dementia will be compared with effects that other activities provided in the care facility where participants live, may have on the same participants.

AAT is defined as an activity provided by a handler and his/her animal (e.g., dog, cat, rabbit, bird, horse) for somebody living with a certain medical condition/illness. AAT is different than Assistant Dogs/Animal (e.g., guide dogs for the blind), who have a very specific training. In this research, we will focus mostly on therapy-dogs and therapy-owls for people with dementia living in care homes.

The research will be conducted over a period of 12 months. The primary methods that will be used are participant observation (accompanying and observing volunteers during animal-assisted therapy meetings and various activities in the care homes) and interviewing the residents, care homes' staff, volunteers, canine trainers and veterinarians. Additional data will be collected through document analysis (consulting care home policies and participants' care plans and medical notes) and auto-ethnography (auto-observations of interactions between the student and 2 dogs).

The instruments described in the outcome measures are used as guidance only. As this research is non-quantitative, the items listed in the scale instruments are not administered like in a usual clinical testing. The specificity of anthropological research, especially in regard to the use of its methods (participant observation, triangulated with in-depth interview, document analysis and auto-ethnography) addresses implicitly the limitations of such instruments.

While the focus of the research remains on the interactions between people with dementia and therapy-animals, the involvement of the other participants offers different perspectives of looking at these interactions and at their context. For anthropological research, it is fundamental that a certain topic/issue is addressed in its context by gathering information from multiple perspectives. This has been documented as being one of the biggest strengths of anthropological research investigating a clinical-related topic.

The aim of this research is to understand what are the effects that therapy-animals can have on people living with dementia (in moderate and severe stages) in a care facility. While it doesn't aim to compare people living with dementia in their own homes and their potential interaction with a therapy-animal, the research compares the effects of AAT with other activities (e.g., music therapy; craft therapy) and in the context of human interactions (e.g., interactions with other residents; care facility staff members; family members). Because it is documented that animals' therapeutic effects are possible through bond transference, the research also looks as part of the context at how the human-animal bond is formed, how can be transferred and how participants may develop a bond with the therapy-animal. This will be done by interviewing therapy-animal volunteers; canine trainers; and veterinarians. While these might appear as two different projects, we argue that this perspective (how the human-animal bond is formed and its potential therapeutic effect in being transferred) can offer new and original insights in understanding dementia and its stages, as well as a more accurate understanding of AAT effects on people with moderate and severe dementia.

Although the benefits of Animal-Assisted Therapy have been previously documented, these were mostly statistical or experimental studies. To date, there is no study that explores the relationship between therapy-animals and people with dementia using a long-term qualitative approach. Almost all the studies consulted in preparation for our protocol recommend a research that approaches AAT for people with dementia in the context of social interactions and living conditions and from the perspectives described by us. The lack of the context and of these perspectives have been documented/acknowledged as limitations of previous studies in understanding the effects of AAT for people with dementia. These limitations are addressed in our study by looking at them from the diversity of the perspectives we propose.

Given the increased number of people living with dementia, the moral imperative of offering them activities that enhance their quality of life especially in later stages, as well as the rising literature documenting the benefits of companion animals, we aim that this research to contribute to new approaches and policies of care for people with moderate and severe dementia.

Conditions
Dementia
Being tested
Interactions with therapy-animals
Keywords
dementia, Animal-Assisted Therapy, ethnography, qualitative study
Medical subject headings
Dementia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Interactions with therapy-animalsOther

    How people interact with humans and non-humans animals during and outside visits from therapy-animal teams.

Study groups in NCT03946696
Study groupRoleWhat they receive
DementiaObservations of communication and interactions between people with dementia living in a care home and therapy-animals.
Receives: Other: Interactions with therapy-animals

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Behavioural and Psychological Symptoms of Dementia (BPSD)

    Observations of behaviours associated with dementia (wandering; agitation; anxiety; irritability; apathy; disinhibition). Please note this is a qualitative study that does not use measuring tools.

    Measured: 12 months

  2. Symptoms of Depression in dementia

    Observation - Please note this is a qualitative study that does not use measuring tools.

    Measured: 12 months

  3. Verbal and non-verbal aspects of communication in dementia (e.g., smile; touch; direction of gaze); words.

    Observations and interviews - Please note this is a qualitative study that does not use measuring tools.

    Measured: 12 months

Secondary outcomes (1)
  1. Patient experience of Animal-Assisted Therapy visits

    Qualitative evaluation of patient experience of visits from a therapy-animal team assessed in qualitative in-depth interviews.

    Measured: 15 minutes-1 hour

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 May 2019
  2. Study start15 Jan 2022
  3. Primary completion31 Dec 2022
  4. Study completion31 Dec 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03946696
Sponsor's protocol ID
2-097-18
Acronym
AATPD
Status last verified
Jan 2022
First submitted
29 Oct 2018
Last updated
14 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Only the main researcher Cristina Douglas will have access to primary data.

Questions about this trial

What is this clinical trial studying?

An observational study of Dementia, run by University of Aberdeen at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Behavioural and Psychological Symptoms of Dementia (BPSD) (time frame: 12 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 May 2026; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in